Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 25% ± 8% | |
glutamatergic neuron | 9 studies | 41% ± 25% | |
adipocyte | 9 studies | 26% ± 8% | |
ciliated cell | 9 studies | 25% ± 11% | |
fibroblast | 8 studies | 21% ± 4% | |
microglial cell | 7 studies | 23% ± 7% | |
astrocyte | 7 studies | 33% ± 17% | |
oligodendrocyte precursor cell | 7 studies | 23% ± 9% | |
retinal cone cell | 6 studies | 19% ± 5% | |
endothelial cell of lymphatic vessel | 6 studies | 32% ± 7% | |
neuron | 5 studies | 36% ± 17% | |
retinal rod cell | 5 studies | 21% ± 4% | |
epithelial cell | 5 studies | 37% ± 9% | |
GABAergic neuron | 5 studies | 43% ± 19% | |
macrophage | 5 studies | 32% ± 3% | |
pericyte | 5 studies | 20% ± 4% | |
type I pneumocyte | 5 studies | 22% ± 6% | |
type II pneumocyte | 5 studies | 20% ± 4% | |
cardiac muscle cell | 4 studies | 30% ± 3% | |
lymphocyte | 4 studies | 18% ± 2% | |
myeloid cell | 4 studies | 23% ± 4% | |
dendritic cell | 4 studies | 20% ± 4% | |
club cell | 4 studies | 22% ± 7% | |
interneuron | 4 studies | 40% ± 24% | |
oligodendrocyte | 4 studies | 27% ± 11% | |
hepatocyte | 3 studies | 26% ± 12% | |
connective tissue cell | 3 studies | 17% ± 1% | |
alveolar macrophage | 3 studies | 24% ± 9% | |
monocyte | 3 studies | 25% ± 4% | |
basal cell | 3 studies | 32% ± 18% | |
smooth muscle cell | 3 studies | 20% ± 2% | |
mast cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 804.48 | 1445 / 1445 | 100% | 9.12 | 183 / 183 |
breast | 100% | 1015.04 | 459 / 459 | 100% | 16.44 | 1117 / 1118 |
uterus | 100% | 909.50 | 170 / 170 | 100% | 7.63 | 457 / 459 |
lung | 100% | 806.81 | 578 / 578 | 99% | 8.09 | 1148 / 1155 |
brain | 100% | 561.40 | 2634 / 2642 | 100% | 6.27 | 702 / 705 |
prostate | 100% | 1222.72 | 245 / 245 | 99% | 7.59 | 498 / 502 |
bladder | 100% | 966.05 | 21 / 21 | 99% | 6.91 | 498 / 504 |
ovary | 100% | 660.01 | 180 / 180 | 99% | 6.58 | 424 / 430 |
pancreas | 100% | 502.98 | 327 / 328 | 99% | 6.51 | 176 / 178 |
thymus | 100% | 1266.79 | 653 / 653 | 98% | 6.32 | 594 / 605 |
intestine | 100% | 799.94 | 966 / 966 | 98% | 6.01 | 514 / 527 |
stomach | 100% | 583.29 | 359 / 359 | 97% | 6.30 | 277 / 286 |
kidney | 100% | 804.70 | 89 / 89 | 91% | 5.13 | 819 / 901 |
skin | 100% | 889.23 | 1809 / 1809 | 90% | 6.20 | 424 / 472 |
adrenal gland | 100% | 752.76 | 258 / 258 | 87% | 4.15 | 201 / 230 |
liver | 100% | 417.33 | 226 / 226 | 74% | 3.47 | 302 / 406 |
adipose | 100% | 838.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 910.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.28 | 1 / 1 |
blood vessel | 100% | 826.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 523.04 | 838 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 332.19 | 778 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 3.93 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 51% | 1.91 | 41 / 80 |
peripheral blood | 48% | 243.78 | 442 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016607 | Cellular component | nuclear speck |
GO_0005730 | Cellular component | nucleolus |
GO_0005634 | Cellular component | nucleus |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | GPATCH2 |
Protein name | G patch domain-containing protein 2 |
Synonyms | GPATC2 |
Description | FUNCTION: Enhances the ATPase activity of DHX15 in vitro. . |
Accessions | ENST00000366935.8 [Q9NW75-1] ENST00000366934.3 [Q9NW75-2] Q9NW75 |